Last updated: July 17, 2026

Application No. 18/554,180

METHODS AND COMPOSITIONS COMPRISING MHC CLASS I PEPTIDES

Non-Final OA

Filed

Oct 05, 2023

Priority

Apr 06, 2021 — provisional 63/171,137 +1 more

Examiner

PAGONAKIS, ANNA

Art Unit

6221

Tech Center

6200

Assignee

Board of Regents of the University of Texas System

OA Round

1 (Non-Final)

Interview Optional

— +11.7% interview lift. Interview lift (+11.7%) is below the 15.0% threshold. A written response is recommended.

Based on 952 resolved cases, 2023–2026

Examiner Intelligence

PAGONAKIS, ANNA View full profile →

Grants only 38% of cases

Career Allowance Rate

366 granted / 952 resolved

-21.6% vs TC avg

Moderate +12% lift

Without

With

+11.7%

Interview Lift

resolved cases with interview

Typical timeline

3y 0m

Avg Prosecution

30 currently pending

Career history

957

Total Applications

across all art units

Statute-Specific Performance

§101

0.5%

-39.5% vs TC avg

§103

55.3%

+15.3% vs TC avg

§102

10.7%

-29.3% vs TC avg

§112

11.3%

-28.7% vs TC avg

Black line = Tech Center average estimate • Based on career data from 952 resolved cases

Prosecution Timeline

Oct 05, 2023

Application Filed

Jun 01, 2026

Non-Final Rejection mailed (current)

Precedent Cases

Applications granted by this same examiner with similar technology

16/817,830

Patent 11207323

NULL

Granted Dec 28, 2021

16/666,278

Patent 11192869

NULL

Granted Dec 07, 2021

15/923,244

Patent 11179395

NULL

Granted Nov 23, 2021

16/543,079

Patent 11173159

NULL

Granted Nov 16, 2021

16/991,863

Patent 11173160

NULL

Granted Nov 16, 2021

Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.

Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2

Expected OA Rounds

38%

Grant Probability

50%

With Interview (+11.7%)

3y 0m (~2m remaining)

Median Time to Grant

Low

PTA Risk

Based on 952 resolved cases by this examiner. Grant probability derived from career allowance rate.

METHODS AND COMPOSITIONS COMPRISING MHC CLASS I PEPTIDES

Interview Optional

Examiner Intelligence

Statute-Specific Performance

Prosecution Timeline

Precedent Cases

Applications granted by this same examiner with similar technology

Strategy Recommendation AI-generated — please review before filing

Prosecution Projections

Ready to respond to this office action?

Sign in with your work email